Machine learning is helping neuroscientists organize vast quantities of cells’ genetic data in the latest neurobiological cartography effort.

On February 12, 2026, NewcelX announced a peer-reviewed review article in Clinical Drug Investigation analyzing Mazindol immediate-release/sustained-release (IR/SR), highlighting a 50-year ...

This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...

A newly published scientific paper titled "Gene Expression Patterns in Lung Adenocarcinoma Cells in Response to Changes in Deuterium Concentration" ...

QT Sense raises €4M to advance a quantum sensing platform that lets researchers watch living cells and study disease ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and ...

Tr1X, a clinical-stage autoimmune and inflammatory disease company developing Type 1 regulatory T (Tr1) cell therapies, today announced the first clinical data from its ongoing Phase 1 study of TRX103 ...

Advancements in spatial proteomics enable detailed tissue mapping, linking protein localization to disease mechanisms and enhancing translational research.

Researchers identify beta catenin protein degradation as a therapeutic vulnerability in B cell acute lymphoblastic leukaemia, supporting the repurposing of glycogen synthase kinase 3 beta inhibitors.

Approximately SEK 91 million (gross) raised in December, strengthening financial position with additional warrant upside in 2026.Mitazalimab validation: OPTIMIZE-1 biomarker results published in Cell ...

In some ways, data and its quality can seem strange to people used to assessing the quality of software. There’s often no observable behaviour to check and little in the way of structure to help you ...

Researchers in China validated the updated SOFA-2 score specifically in sepsis using data from a multicenter randomized trial ...